AVP

protein-coding

arginine vasopressin, the group of Neuropeptides

Gene summary

This gene encodes a member of the vasopressin/oxytocin family and preproprotein that is proteolytically processed to generate multiple protein products. These products include the neuropeptide hormone arginine vasopressin, and two other peptides, neurophysin 2 and copeptin. Arginine vasopressin is a posterior pituitary hormone that is synthesized in the supraoptic nucleus and paraventricular nucleus of the hypothalamus. Along with its carrier protein, neurophysin 2, it is packaged into neurosecretory vesicles and transported axonally to the nerve endings in the neurohypophysis where it is either stored or secreted into the bloodstream. The precursor is thought to be activated while it is being transported along the axon to the posterior pituitary. Arginine vasopressin acts as a growth factor by enhancing pH regulation through acid-base transport systems. It has a direct antidiuretic action on the kidney, and also causes vasoconstriction of the peripheral vessels. This hormone can contract smooth muscle during parturition and lactation. It is also involved in cognition, tolerance, adaptation and complex sexual and maternal behaviour, as well as in the regulation of water excretion and cardiovascular functions. Mutations in this gene cause autosomal dominant neurohypophyseal diabetes insipidus (ADNDI). This gene is present in a gene cluster with the related gene oxytocin on chromosome 20. [provided by RefSeq, Nov 2015]

Previous symbols:
  • ARVP

MANE transcript

NM_000490.5

Inheritance

AD, AR

ClinVar variants

P:45U:78B:30

Top phenotype

Diabetes insipidus, neurohypophyseal

gnomAD constraint

pLI —, LoF o/e 0.48

Max pathogenic AF

—

Genomic locus

chr20:3,082,556-3,084,724

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~2.2 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

neurohypophyseal diabetes insipidusSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0007450

Submitter: PanelApp Australia

neurohypophyseal diabetes insipidusSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0007450

Submitter: Labcorp Genetics (formerly Invitae)

neurohypophyseal diabetes insipidusSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0007450

Submitter: Orphanet

Clinical Genomic Database (CGD)

Diabetes insipidus, neurohypophysealAD/AR

Manifestation: Endocrine; Renal

Intervention: Endocrine; Renal

Rationale: Treatment/prevention of hypernatremia can be effective; Medications related to osteoporosis/osteopenia may be beneficial

Refs: 10404801; 10369876; 14673472; 15070970; 22524462Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to AVP variants in ClinVar

7 Conditions Cataloged
not providedTotal: 76
Neurohypophyseal diabetes insipidusTotal: 66
Inborn genetic diseasesTotal: 29
AVP-related disorderTotal: 24
not specifiedTotal: 5
Diabetes insipidus, neurohypophyseal, autosomal recessiveTotal: 1
early-onset neurohypophyseal diabetes insipidusTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_000490.5. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
1
clinvar
21
clinvar
1
clinvar
24
missense
19
clinvar
15
clinvar
74
clinvar
6
clinvar
2
clinvar
116
nonsense
3
clinvar
1
clinvar
2
clinvar
6
start loss
1
clinvar
1
clinvar
2
frameshift
1
clinvar
1
splice donor/acceptor (+/-2bp)
1
clinvar
2
clinvar
1
clinvar
4
Total252078273153

Highest pathogenic variant AF is 0.00005081156

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 2 of 2 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_000490.5RefSeqNP_000481.23MANE Select
ENST00000380293.3EnsemblENSP00000369647.33MANE Select

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Vasopressin-regulated water reabsorption - Homo sapiens (human)
  • Phospholipase D signaling pathway - Homo sapiens (human)
  • BMAL1-CLOCK,NPAS2 activates circadian gene expression
  • Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways
  • Signaling by GPCR

Biological Process

  • maternal aggressive behavior
  • positive regulation of systemic arterial blood pressure
  • renal water homeostasis
  • generation of precursor metabolites and energy
  • water transport

Molecular Function

  • protein kinase activity
  • signaling receptor binding
  • neuropeptide hormone activity
  • neurohypophyseal hormone activity
  • V1A vasopressin receptor binding

Cellular Component

  • extracellular region
  • extracellular space
  • cytosol
  • secretory granule
  • dendrite

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000380293
Coding exons
3
Length
2169
Individuals with no LoFs
125584
Homozygous LoFs
0
Heterozygous LoFs
6
Defined
125590
p
0.0000239
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense1.054063.70.6280.000003511025
Missense (PolyPhen)1027.3710.36534352
Synonymous0.4682730.30.8920.00000204330
Loss of Function0.98124.160.4811.78e-758

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)0.0000440.000044rare
South Asian0.0000330.000033rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Neurophysin 2 specifically binds vasopressin.;
Disease
DISEASE: Diabetes insipidus, neurohypophyseal (NDI) [MIM:125700]: A disease characterized by persistent thirst, polydipsia and polyuria. Affected individuals are apparently normal at birth, but characteristically develop symptoms of vasopressin deficiency during childhood. {ECO:0000269|PubMed:10369876, ECO:0000269|PubMed:10487710, ECO:0000269|PubMed:10677561, ECO:0000269|PubMed:11017955, ECO:0000269|PubMed:11150885, ECO:0000269|PubMed:11161827, ECO:0000269|PubMed:11443218, ECO:0000269|PubMed:11748489, ECO:0000269|PubMed:11980620, ECO:0000269|PubMed:12012274, ECO:0000269|PubMed:12107248, ECO:0000269|PubMed:12359138, ECO:0000269|PubMed:12519420, ECO:0000269|PubMed:12931042, ECO:0000269|PubMed:14510916, ECO:0000269|PubMed:14673472, ECO:0000269|PubMed:15538939, ECO:0000269|PubMed:1740104, ECO:0000269|PubMed:7714110, ECO:0000269|PubMed:8045958, ECO:0000269|PubMed:8103767, ECO:0000269|PubMed:8370682, ECO:0000269|PubMed:8514868, ECO:0000269|PubMed:8554046, ECO:0000269|PubMed:9360520, ECO:0000269|PubMed:9580132, ECO:0000269|PubMed:9814475}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
K
Indispensability pred.
E
Indispensability score
0.585

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.